1. Agarwala S, Shah S, Joshi VR. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years. J Bone Joint Surg Br 2009; 91:1013.
2. Lai KA, Shen WJ, Yang CY, et al. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am 2005; 87:2155.
3. Chen CH, Chang JK, Lai KA, et al. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2012; 64:1572.
4. Yuan HF, Guo CA, Yan ZQ. The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials. Osteoporos Int 2016; 27:295.
5. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res 2001; :173
.6. Claßen T, Becker A, Landgraeber S, et al. Long-term Clinical Results after Iloprost Treatment for Bone Marrow Edema and Avascular Necrosis. Orthop Rev (Pavia). 2016;8(1):6150. Published 2016 Mar 31. doi:10.4081/or.2016.6150
7. Wang CJ, Huang CC, Yip HK, Yang YJ. Dosage effects of extracorporeal shockwave therapy in early hip necrosis. Int J Surg 2016; 35:179
8. Massari L, Fini M, Cadossi R, et al. Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head. J Bone Joint Surg Am 2006; 88 Suppl 3:56.
9. Camporesi EM, Vezzani G, Bosco G, et al. Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplasty 2010; 25:118.
10. Koren L, Ginesin E, Melamed Y, et al. Hyperbaric oxygen for stage I and II femoral head osteonecrosis. Orthopedics 2015; 38:e200
11. Cebrian JL, Milano GL, Francis A, Lopiz Y, Marco F, Lopez-Duran L. Role of electromagnetic stimulation in the treatment of osteonecrosis of the femoral head in early stages. J Biomed Sci Eng. 2014:252–7.
12. Bassett CA, Schink-Ascani M, Lewis SM. Effects of pulsed electromagnetic fields on Steinberg ratings of femoral head osteonecrosis. Clin Orthop Relat Res. 1989;246:172–185.
13. F. Gao, W. Sun, Z. Li et al., “High-Energy Extracorporeal Shock Wave for Early Stage Osteonecrosis of the Femoral Head: A Single-Center Case Series,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, 2015.
14. C.-J. Wang, C.-C. Huang, J.-W. Wang, T. Wong, and Y.-J. Yang, “Long-term results of extracorporeal shockwave therapy and core decompression in osteonecrosis of the femoral head with eight- to nine-year follow-up,” Biomedical Journal, vol. 35, no. 6, pp. 481–485, 2012.
15. J. Y. Lee, J. W. Kwon, J. S. Park et al., “Osteonecrosis of Femoral Head Treated with Extracorporeal Shock Wave Therapy: Analysis of Short-term Clinical Outcomes of Treatment with Radiologic Staging,” in Hip & pelvis, pp. 250–257, 2015.
16. Koren L, Ginesin E, Melamed Y, Norman D, Levin D, Peled E (2015). Hyperbaric oxygen for stage I and II femoral head osteonecrosis. Orthopedics 38: e200–e205.
17. Steinberg ME, Larcom P, Strafford B, Hosick WB, Corces A, Bands RE, et al. Treatment of osteonecrosis of the femoral head by Core decompression, bone grafting, and electrical stimulation. UPOJ. 1997;10:24–29
18. Pierce TP, Jauregui JJ, Elmallah RK, Lavernia CJ, Mont MA, Nace J. A current review of core decompression in the treatment of osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015;8(3):228–232. doi:10.1007/s12178-015-9280-0
19. Fairbank AC, Bhatia D, Jinnah RH, Hungerford DS. Long-term results of core decompression for ischaemic necrosis of the femoral head. J Bone Joint Surg. 1995;77(1):42.
20. Zuo W, Sun W, Zhao D, Gao F, Su Y, et al. (2016) Correction: Investigating Clinical Failure of Bone Grafting through a Window at the Femoral Head Neck Junction Surgery for the Treatment of Osteonecrosis of the Femoral Head. PLOS ONE 11(7): e0160163
21. Li X, Xu X, Wu W. Comparison of bone marrow mesenchymal stem cells and core decompression in treatment of osteonecrosis of the femoral head: a meta-analysis. Int J Clin Exp Pathol. 2014;7(8):5024.
22. Hua, K., Yang, X., Feng, J. et al. The efficacy and safety of core decompression for the treatment of femoral head necrosis: a systematic review and meta-analysis. J Orthop Surg Res 14, 306 (2019). https://doi.org/10.1186/s13018-019-1359-7
23. Landgraeber S, Warwas S, Claßen T, Jäger M. Modifications to advanced Core decompression for treatment of Avascular necrosis of the femoral head. BMC Musculoskelet Disord. 2017;18(1):479. Published 2017 Nov 21. doi:10.1186/s12891-017-1811-y
24. Kim SY, Kim YG, Kim PT, Ihn JC, Cho BC, Koo KH. Vascularized compared with nonvascularized fibular grafts for large osteonecrotic lesions of the femoral head. J Bone Joint Surg Am. 2005;87(9):2012–2018. doi: 10.2106/JBJS.D.02593
25. Sugioka Y. Transtrochanteric anterior rotational osteotomy for the femoral head in the treatment of osteonecrosis affecting the hip: a new osteotomy operation. Clin Orthop Relat Res1978; 130:191–201.
26. Belal MA, Reichelt A. Clinical results of rotational osteotomy for treatment of avascular necrosis of the femoral head. Arch Orthop Trauma Surg 1996; 115:80–84. doi: 10.1007/bf00573446.
27. Inao S, Ando M, Gotoh E, Matsuno T. Minimum 10-year results of Sugioka’s osteotomy for femoral head osteonecrosis. Clin Orthop Relat Res 1999; 368:141–148.
28. Iwasada S, Hasegawa Y, Iwase T, Kitamura S, Iwata H. Transtrochanteric rotational osteotomy for osteonecrosis of the femoral head 43 patients followed for at least 3 years. Arch Orthop Trauma Surg 1997; 116:447–453. doi: 10.1007/bf00387576.
29. Xu, Ying-Xing, et al. “Hip survival rate in the patients with avascular necrosis of femoral head after transtrochanteric rotational osteotomy: a systematic review and meta-analysis.” (2019): 2960-2971.
30. D. Zhao, Y. Zhang, W. Wang, et al. Tantalum rod implantation and vascularized iliac grafting for osteonecrosis of the femoral head. Orthopedics, 36 (6) (2013 Jun), pp. 789-795
31. Hamilton TW, Goodman SM, Figgie M. SAS Weekly Rounds : Avascular necrosis. HSS J 2009 ; 5 : 99-113.
32. Kim, Young-Hoo, et al. “Contemporary total hip arthroplasty with and without cement in patients with osteonecrosis of the femoral head: a concise follow-up, at an average of seventeen years, of a previous report.” JBJS 93.19 (2011): 1806-1810.
33. Chiu KH, Shen WY, Ko CK, Chan KM. Osteonecrosis of the femoral head treated with cementless total hip arthroplasty. A comparison with other diagnoses. J Arthroplasty 1997 ; 12 : 683-688.
34. Dorr LD, Kane TJ, Conaty JP. Arthroplasty in patients 45 years old or younger. A 16-year follow-up study. J Arthroplasty 1994 ; 9 : 453-456.
35. Dudkiewicz I, Covo A, Salai M et al. Total hip arthroplasty after avascular necrosis of the femoral head : does etiology affect the results ? Arch Orthop Trauma Surg 2004 ; 124 : 82-85
36. Kim YH, Choi Y, Kim JS. Cementless total hip arthroplasty with ceramic-on-ceramic bearing in patients younger than 45 years with femoral-head osteonecrosis. Int Orthop 2010 ; 34 : 1123-1127.
37. Kim YH, Oh SH, Kim JS. Primary total hip arthroplasty with a second-generation cementless total hip prosthesis in patients younger than fifty years of age. J Bone Joint Surg 2003 ; 85-A : 109-114.
38. Atrey A, Wolfstadt JI, Hussain N, Khoshbin A, Ward S, Shahid M, et al. The ideal total hip replacement bearing surface in the young patient: a prospective randomized trial comparing alumina ceramic-on-ceramic with ceramic-on-conventional polyethylene:15-year follow-up. J Arthroplast. 2018;33(6):1752–6.
39. Feng, B., Ren, Y., Cao, S. et al. Comparison of ceramic-on-ceramic bearing vs ceramic-on-highly cross-linked polyethylene-bearing surfaces in total hip arthroplasty for avascular necrosis of femoral head: a prospective cohort study with a mid-term follow-up. J Orthop Surg Res 14, 388 (2019).
40. D. van der Jagt, L. Mokete, J. Pietrzak, C. G. Zalavras, and J. R. Lieberman, “Osteonecrosis of the femoral head: evaluation and treatment,” The Journal of the American Academy of Orthopaedic Surgeons, vol. 23, no. 2, pp. 69-70, 2015.
41. J. Pak, “Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads,” Pain Physician, vol. 15, no. 1, pp. 75–85, 2012.
42. J. Pak, “Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series,” Journal of Medical Case Reports, vol. 5, no. 1, 2011.
43. J. Pak, J. H. Lee, J. H. Jeon, and S. H. Lee, “Complete resolution of avascular necrosis of the human femoral head treated with adipose tissue-derived stem cells and platelet-rich plasma,” The Journal of International Medical Research, vol. 42, no. 6, pp. 1353–1362, 2014.
44. Han, Jun, et al. “The Use of Platelet-Rich Plasma for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review.” BioMed Research International 2020 (2020).